NCT05116579View on ClinicalTrials.gov

Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)

RecruitingOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

October 31, 2021

Primary Completion Date

March 31, 2023

Study Completion Date

August 31, 2025

Conditions

Metastatic Castration-resistant Prostate Cancer

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER